Recent Upgrades & Downgrades
| Date | Symbol | Action | Broker / Analyst | Change | Price Target |
|---|---|---|---|---|---|
| Feb 3, 2023 | $JWN | Upgrade | Gordon Haskett | Reduce →Hold | $22 |
| Feb 3, 2023 | $META | Upgrade | DZ Bank | Sell →Hold | $180 |
| Feb 2, 2023 | $ASH | Downgrade | JP Morgan | Neutral →Underweight | $105 |
| Feb 2, 2023 | $ASTR | Downgrade | Deutsche Bank | Buy →Hold | $1 |
| Feb 2, 2023 | $FBIN | Downgrade | Loop Capital | Buy →Hold | $65 |
| Feb 2, 2023 | $FSLR | Downgrade | BofA Securities | Buy →Neutral | $195 |
| Feb 2, 2023 | $FTNT | Downgrade | BMO Capital Markets | Outperform →Market Perform | $57 |
| Feb 2, 2023 | $GRAB | Downgrade | JP Morgan | Neutral →Underweight | $2.8 |
| Feb 2, 2023 | $GXO | Downgrade | Exane BNP Paribas | Neutral →Underperform | $40 |
| Feb 2, 2023 | $MTCH | Downgrade | Oppenheimer | Outperform →Perform | |
| Feb 2, 2023 | $PTON | Downgrade | Exane BNP Paribas | Neutral →Underperform | $8 |
| Feb 2, 2023 | $PTON | Downgrade | JMP Securities | Mkt Outperform →Mkt Perform | |
| Feb 2, 2023 | $RCM | Downgrade | Truist | Buy →Hold | $15 |
| Feb 2, 2023 | $VRNS | Downgrade | Needham | Buy →Hold | |
| Feb 2, 2023 | $XM | Downgrade | Deutsche Bank | Buy →Hold | $19 |
| Feb 2, 2023 | $ALGN | Upgrade | Goldman | Sell →Neutral | $307 |
| Feb 2, 2023 | $FDX | Upgrade | Citigroup | Neutral →Buy | $240 |
| Feb 2, 2023 | $GGG | Upgrade | Seaport Research Partners | Neutral →Buy | $82 |
| Feb 2, 2023 | $META | Upgrade | BofA Securities | Neutral →Buy | $220 |
| Feb 2, 2023 | $META | Upgrade | Piper Sandler | Neutral →Overweight | $215 |
| Feb 2, 2023 | $META | Upgrade | Rosenblatt | Neutral →Buy | $220 |
| Feb 2, 2023 | $NGVT | Upgrade | Loop Capital | Hold →Buy | $100 |
| Feb 2, 2023 | $OI | Upgrade | RBC Capital Mkts | Sector Perform →Outperform | $34 |
| Feb 2, 2023 | $OKTA | Upgrade | Needham | Hold →Buy | $90 |
| Feb 2, 2023 | $SLAB | Upgrade | Summit Insights | Hold →Buy | |
| Feb 2, 2023 | $TRP | Upgrade | CIBC | Neutral →Sector Outperform | |
| Feb 2, 2023 | $META | Reiterated | Monness Crespi & Hardt | Buy | $240 |
| Feb 2, 2023 | $META | Reiterated | Morgan Stanley | Equal-Weight | $190 |
| Feb 2, 2023 | $META | Reiterated | Raymond James | Outperform | $220 |
| Feb 2, 2023 | $META | Reiterated | Robert W. Baird | Outperform | $205 |
| Feb 2, 2023 | $META | Reiterated | JP Morgan | Overweight | $225 |
| Feb 2, 2023 | $META | Reiterated | Stifel | Buy | $210 |
| Feb 2, 2023 | $META | Reiterated | JMP Securities | Mkt Outperform | $210 |
| Feb 2, 2023 | $META | Reiterated | Susquehanna | Positive | $225 |
| Feb 2, 2023 | $META | Reiterated | SVB Securities | Outperform | $255 |
| Feb 2, 2023 | $META | Reiterated | UBS | Buy | $235 |
| Feb 2, 2023 | $META | Reiterated | Wolfe Research | Outperform | $220 |
| Feb 2, 2023 | $META | Reiterated | ROTH Capital | Buy | $210 |
| Feb 2, 2023 | $META | Reiterated | Guggenheim | Buy | $210 |
| Feb 2, 2023 | $META | Reiterated | Mizuho | Buy | $210 |
| Feb 2, 2023 | $META | Reiterated | Jefferies | Buy | $225 |